Closure for the purpose of consideration of Audited (standalone and Consolidated) Results for the quarter and Financial year ending 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Drugs Limited has informed BSE that its trading window will be closed starting Wednesday, 1st April 2026, and will reopen 48 hours after the announcement of audited standalone and consolidated financial results for the quarter and financial year ending 31st March 2026. During this period, all directors, designated employees, insiders, and their immediate relatives are prohibited from trading in the company's securities. The company has confirmed that the date of the board meeting to approve the results will be communicated separately. The intimation is issued in compliance with SEBI's Insider Trading Regulations, 2015.
This is a routine regulatory compliance announcement and does not directly impact shareholders. However, it signals that the company's Q4 and FY26 audited results are forthcoming, which may be a key event for investors to track. The stock could see movement once results are declared.